NOVEL COMPOUNDS AS ROR GAMMA MODULATORS

The present disclosure is directed to compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein ring A, ring B, L, R1, R2, R3, R4, R5, Ra, Rb, n, m, p and q are as defined herein, which are active as modulators of retinoid-related orphan receptor gamma t (RORγt). These compound...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GHARAT Laxmikant Atmaram, HARDE Rajendra Laxman, PARDESHI Shailesh Ramesh, THOMAS Abraham, SHELKE Sandeep Yadunath, BAJPAI Malini, DAS Sanjib, SHAH Daisy Manish, KHAIRATKAR-JOSHI Neelima
Format: Patent
Sprache:eng ; slv
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator GHARAT Laxmikant Atmaram
HARDE Rajendra Laxman
PARDESHI Shailesh Ramesh
THOMAS Abraham
SHELKE Sandeep Yadunath
BAJPAI Malini
DAS Sanjib
SHAH Daisy Manish
KHAIRATKAR-JOSHI Neelima
description The present disclosure is directed to compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein ring A, ring B, L, R1, R2, R3, R4, R5, Ra, Rb, n, m, p and q are as defined herein, which are active as modulators of retinoid-related orphan receptor gamma t (RORγt). These compounds prevent, inhibit, or suppress the action of RORγt and are therefore useful in the treatment of RORγt mediated diseases, disorders, syndromes or conditions such as, e.g., pain, inflammation, COPD, asthma, rheumatoid arthritis, colitis, multiple sclerosis, psoriasis, neurodegenerative diseases and cancer.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_SI3331863TT1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>SI3331863TT1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_SI3331863TT13</originalsourceid><addsrcrecordid>eNrjZFD38w9z9VFw9vcN8A_1cwlWcAxWCPIPUnB39PV1VPD1dwn1cQzxDwrmYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxwZ7GxsaGFmbGISGGxsSoAQD2ESRa</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NOVEL COMPOUNDS AS ROR GAMMA MODULATORS</title><source>esp@cenet</source><creator>GHARAT Laxmikant Atmaram ; HARDE Rajendra Laxman ; PARDESHI Shailesh Ramesh ; THOMAS Abraham ; SHELKE Sandeep Yadunath ; BAJPAI Malini ; DAS Sanjib ; SHAH Daisy Manish ; KHAIRATKAR-JOSHI Neelima</creator><creatorcontrib>GHARAT Laxmikant Atmaram ; HARDE Rajendra Laxman ; PARDESHI Shailesh Ramesh ; THOMAS Abraham ; SHELKE Sandeep Yadunath ; BAJPAI Malini ; DAS Sanjib ; SHAH Daisy Manish ; KHAIRATKAR-JOSHI Neelima</creatorcontrib><description>The present disclosure is directed to compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein ring A, ring B, L, R1, R2, R3, R4, R5, Ra, Rb, n, m, p and q are as defined herein, which are active as modulators of retinoid-related orphan receptor gamma t (RORγt). These compounds prevent, inhibit, or suppress the action of RORγt and are therefore useful in the treatment of RORγt mediated diseases, disorders, syndromes or conditions such as, e.g., pain, inflammation, COPD, asthma, rheumatoid arthritis, colitis, multiple sclerosis, psoriasis, neurodegenerative diseases and cancer.</description><language>eng ; slv</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20200731&amp;DB=EPODOC&amp;CC=SI&amp;NR=3331863T1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20200731&amp;DB=EPODOC&amp;CC=SI&amp;NR=3331863T1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GHARAT Laxmikant Atmaram</creatorcontrib><creatorcontrib>HARDE Rajendra Laxman</creatorcontrib><creatorcontrib>PARDESHI Shailesh Ramesh</creatorcontrib><creatorcontrib>THOMAS Abraham</creatorcontrib><creatorcontrib>SHELKE Sandeep Yadunath</creatorcontrib><creatorcontrib>BAJPAI Malini</creatorcontrib><creatorcontrib>DAS Sanjib</creatorcontrib><creatorcontrib>SHAH Daisy Manish</creatorcontrib><creatorcontrib>KHAIRATKAR-JOSHI Neelima</creatorcontrib><title>NOVEL COMPOUNDS AS ROR GAMMA MODULATORS</title><description>The present disclosure is directed to compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein ring A, ring B, L, R1, R2, R3, R4, R5, Ra, Rb, n, m, p and q are as defined herein, which are active as modulators of retinoid-related orphan receptor gamma t (RORγt). These compounds prevent, inhibit, or suppress the action of RORγt and are therefore useful in the treatment of RORγt mediated diseases, disorders, syndromes or conditions such as, e.g., pain, inflammation, COPD, asthma, rheumatoid arthritis, colitis, multiple sclerosis, psoriasis, neurodegenerative diseases and cancer.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFD38w9z9VFw9vcN8A_1cwlWcAxWCPIPUnB39PV1VPD1dwn1cQzxDwrmYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxwZ7GxsaGFmbGISGGxsSoAQD2ESRa</recordid><startdate>20200731</startdate><enddate>20200731</enddate><creator>GHARAT Laxmikant Atmaram</creator><creator>HARDE Rajendra Laxman</creator><creator>PARDESHI Shailesh Ramesh</creator><creator>THOMAS Abraham</creator><creator>SHELKE Sandeep Yadunath</creator><creator>BAJPAI Malini</creator><creator>DAS Sanjib</creator><creator>SHAH Daisy Manish</creator><creator>KHAIRATKAR-JOSHI Neelima</creator><scope>EVB</scope></search><sort><creationdate>20200731</creationdate><title>NOVEL COMPOUNDS AS ROR GAMMA MODULATORS</title><author>GHARAT Laxmikant Atmaram ; HARDE Rajendra Laxman ; PARDESHI Shailesh Ramesh ; THOMAS Abraham ; SHELKE Sandeep Yadunath ; BAJPAI Malini ; DAS Sanjib ; SHAH Daisy Manish ; KHAIRATKAR-JOSHI Neelima</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_SI3331863TT13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; slv</language><creationdate>2020</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>GHARAT Laxmikant Atmaram</creatorcontrib><creatorcontrib>HARDE Rajendra Laxman</creatorcontrib><creatorcontrib>PARDESHI Shailesh Ramesh</creatorcontrib><creatorcontrib>THOMAS Abraham</creatorcontrib><creatorcontrib>SHELKE Sandeep Yadunath</creatorcontrib><creatorcontrib>BAJPAI Malini</creatorcontrib><creatorcontrib>DAS Sanjib</creatorcontrib><creatorcontrib>SHAH Daisy Manish</creatorcontrib><creatorcontrib>KHAIRATKAR-JOSHI Neelima</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GHARAT Laxmikant Atmaram</au><au>HARDE Rajendra Laxman</au><au>PARDESHI Shailesh Ramesh</au><au>THOMAS Abraham</au><au>SHELKE Sandeep Yadunath</au><au>BAJPAI Malini</au><au>DAS Sanjib</au><au>SHAH Daisy Manish</au><au>KHAIRATKAR-JOSHI Neelima</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NOVEL COMPOUNDS AS ROR GAMMA MODULATORS</title><date>2020-07-31</date><risdate>2020</risdate><abstract>The present disclosure is directed to compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein ring A, ring B, L, R1, R2, R3, R4, R5, Ra, Rb, n, m, p and q are as defined herein, which are active as modulators of retinoid-related orphan receptor gamma t (RORγt). These compounds prevent, inhibit, or suppress the action of RORγt and are therefore useful in the treatment of RORγt mediated diseases, disorders, syndromes or conditions such as, e.g., pain, inflammation, COPD, asthma, rheumatoid arthritis, colitis, multiple sclerosis, psoriasis, neurodegenerative diseases and cancer.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; slv
recordid cdi_epo_espacenet_SI3331863TT1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title NOVEL COMPOUNDS AS ROR GAMMA MODULATORS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T12%3A44%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GHARAT%20Laxmikant%20Atmaram&rft.date=2020-07-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ESI3331863TT1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true